Next, we inhibited FAK phosphorylation using the small-molecule inhibitor PF-573228, which disrupted CAF-induced FAK signaling activation and migration in cancer cells (Fig. 4E–G, Additional file 1: Figs. S3F and S6B). Here, PTK2 is linked to cancer.